2m 2m 2m 2m 2m 2m 2m
LataMed AI (LMED)
OTC
$2.44-$0.05 (-2.01%)
Price as of Jun 03, 2026- $128.5MMarket Cap
- N/A1-Year Change
- N/AIndustry
LataMed AI (LMED)
$2.44-$0.05 (-2.01%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 0 N/A | 0 N/A | |
Cost of Revenue | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | |
Total Operating Expenses | 171,852 -94.79% | 3.3M N/A | |
Operating Profit | -171,852 -94.79% | -3.3M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | -35,633 -3.07% | -36,762 N/A | |
Interest Income and Expense and Net | -35,633 -3.07% | -36,762 N/A | |
Total Nonoperating Income and Expense | -35,633 -196.78% | 36,820 N/A | |
Income before Taxes | -207,485 -93.64% | -3.3M N/A | |
Income Taxes | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | -207,485 -93.64% | -3.3M N/A | |
Net Income from Continuing Operations Applicable to Common | -207,485 -93.64% | -3.3M N/A | |
Basic EPS and Net Income | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | N/A N/A | -0.11 N/A | |
Basic Weighted Average Shares | N/A N/A | 29.3M N/A | |
Diluted Weighted Average Shares | N/A N/A | 29.3M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 0 N/A | 0 N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 0 N/A | 0 N/A | |
Total Current Assets | 0 N/A | 0 N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | N/A N/A | N/A N/A | |
Total Long-Term Assets | N/A N/A | N/A N/A | |
Total Assets | 0 N/A | 0 N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | 272,304 +25.65% | 216,713 N/A | |
Total Current Liabilities | 630,860 +9.99% | 573,575 N/A | |
Total Long-Term Debt | 34,591 0.00% | 34,591 N/A | |
Total Long-Term Liabilities | N/A N/A | N/A N/A | |
Total Liabilities | 630,860 +9.99% | 573,575 N/A | |
Retained Earnings | -29.6M +0.71% | -29.4M N/A | |
Total Stockholders Equity | -630,860 +9.99% | -573,575 N/A | |
Total Shares Outstanding | 44.3M +51.30% | 29.3M N/A | |
Cash Flow | |||
Cash from Operating Activities | -205,791 +207.91% | -66,834 N/A | |
Capital Expenditures | N/A N/A | N/A N/A | |
Cash from Investing Activities | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | 205,791 +207.91% | 66,834 N/A | |
Financials Ratio | |||
Gross Margin | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | |
Return on Assets | N/A N/A | N/A N/A | |
Return on Equity | N/A N/A | N/A N/A | |
Revenue Growth | N/A N/A | N/A N/A | |
Current Ratio | 0.00 N/A | N/A N/A | |
Cash Ratio | 0.00 N/A | N/A N/A | |
Debt-to-Equity Ratio | -0.49 N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow